<TEXT>&#2;<DATELINE>2005-12-31</DATELINE><TITLE>Ribavarin Should Be Tested in Clinical Trials in Combination With Other Antiviral Agents for Severe Acute Respiratory Syndrome</TITLE><BODY>&#3;</BODY></TEXT>